Young Wendy B.
SEC insider (Form 3/4/5 filer). CIK 0002042847. Director at Rapport Therapeutics, Inc. (RAPP) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in BOSTON, MA.
Companies Young Wendy B. has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director
- ADIAL PHARMACEUTICALS, INC. (ADIL): Director
Young Wendy B.
CIK: 0002042847
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 22, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseDirect3.8K shares at avg. $26.39$100K - Sep 17, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
25.7K shares- - Jun 12, 2026ADIL
ADIAL PHARMACEUTICALS, INC.
PurchaseDirectPre-funded Warrant
36.4K shares at avg. $2.75- - Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
15.2K shares- - Sep 11, 2025RAPP
Rapport Therapeutics, Inc.
PurchaseDirect3.5K shares at avg. $22.60$79K - Jun 17, 2025RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10.9K shares- - Mar 12, 2025RAPP
Rapport Therapeutics, Inc.
PurchaseDirect6K shares at avg. $10.21$61K - Nov 7, 2024RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
29.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  RAPP Rapport Therapeutics, Inc. | Purchase | 3,789 | $26.39 | $99,992 | Direct |
| Sep 17, 2026 |  ADIL ADIAL PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 25,666 | - | - | Direct |
| Jun 12, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | Purchase Pre-funded Warrant | 36,378 | $2.75 | - | Direct |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 15,200 | - | - | Direct |
| Sep 11, 2025 | RAPP Rapport Therapeutics, Inc. | Purchase | 3,500 | $22.60 | $79,100 | Direct |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,925 | - | - | Direct |
| Mar 12, 2025 | RAPP Rapport Therapeutics, Inc. | Purchase | 6,000 | $10.21 | $61,250 | Direct |
| Nov 7, 2024 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 29,756 | - | - | Direct |
1-8 of 8 transactions